MX2022015488A - Tratamiento para la disfuncion auricular. - Google Patents

Tratamiento para la disfuncion auricular.

Info

Publication number
MX2022015488A
MX2022015488A MX2022015488A MX2022015488A MX2022015488A MX 2022015488 A MX2022015488 A MX 2022015488A MX 2022015488 A MX2022015488 A MX 2022015488A MX 2022015488 A MX2022015488 A MX 2022015488A MX 2022015488 A MX2022015488 A MX 2022015488A
Authority
MX
Mexico
Prior art keywords
treatment
atrial dysfunction
atrial
dysfunction
patient
Prior art date
Application number
MX2022015488A
Other languages
English (en)
Spanish (es)
Inventor
Jean-Francois Tamby
Chun Yang
Jay M Edelberg
Marcus Patrick Henze
Gregory Howard Takeo Kurio
Cynthia Lyle Kelly
Rio Carlos L Del
Robert Lee Anderson
Marius P Sumandea
Jitendra Ganju
Original Assignee
Myokardia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myokardia Inc filed Critical Myokardia Inc
Publication of MX2022015488A publication Critical patent/MX2022015488A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
MX2022015488A 2020-06-15 2021-06-14 Tratamiento para la disfuncion auricular. MX2022015488A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063039438P 2020-06-15 2020-06-15
US202063042512P 2020-06-22 2020-06-22
PCT/US2021/037230 WO2021257456A1 (en) 2020-06-15 2021-06-14 Treatment of atrial dysfunction

Publications (1)

Publication Number Publication Date
MX2022015488A true MX2022015488A (es) 2023-03-21

Family

ID=76845320

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022015488A MX2022015488A (es) 2020-06-15 2021-06-14 Tratamiento para la disfuncion auricular.

Country Status (13)

Country Link
US (1) US20230233545A1 (https=)
EP (1) EP4164644A1 (https=)
JP (2) JP7832128B2 (https=)
KR (1) KR20230024977A (https=)
CN (1) CN116056703A (https=)
AU (1) AU2021293817A1 (https=)
BR (1) BR112022025551A2 (https=)
CA (1) CA3180943A1 (https=)
CL (1) CL2022003548A1 (https=)
IL (1) IL298885A (https=)
MX (1) MX2022015488A (https=)
TW (1) TW202214241A (https=)
WO (1) WO2021257456A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11759640B2 (en) * 2022-01-07 2023-09-19 Xyra, Llc Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations
CN116082326B (zh) * 2022-12-16 2024-12-27 药康众拓(江苏)医药科技有限公司北京分公司 一种氘代吡唑磺酰甲基-哌啶异噁唑脲类化合物及其用途
CN117379683B (zh) * 2023-12-12 2024-02-27 苏州晟智医疗科技有限公司 反搏辅助装置、计算设备、存储介质及反搏系统
CN118304374A (zh) * 2024-04-01 2024-07-09 山东省中医药研究院附属医院 一种组合物在制备治疗心动过速和/或瓣膜反流药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4234017B1 (en) * 2015-01-22 2026-04-15 MyoKardia, Inc. Preparation of 4-methylsulfonyl-substituted piperidine urea compounds useful for the treatment of cardiac disorders such as dilated cardiomyopathy (dcm)
US10758525B2 (en) * 2015-01-22 2020-09-01 MyoKardia, Inc. 4-methylsulfonyl-substituted piperidine urea compounds
AU2018266199A1 (en) * 2017-05-10 2019-11-07 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
DK3645002T3 (da) * 2017-06-30 2024-12-16 Amgen Inc Fremgangsmåder til behandling af hjertesvigt med hjerte-sarkomer-aktivatorer
KR20220009440A (ko) * 2019-05-19 2022-01-24 미요카디아, 인크. 화합물 (r)-4-(1-((3-(디플루오로메틸)-1-메틸-1h-피라졸-4-일)술포닐)-1-플루오로에틸)-n-(이속사졸-3-일)피페리딘-1-카르복스아미드를 사용한 수축기 기능장애 및 감소된 박출 계수를 가진 심부전의 치료

Also Published As

Publication number Publication date
EP4164644A1 (en) 2023-04-19
JP7832128B2 (ja) 2026-03-17
BR112022025551A2 (pt) 2023-03-07
US20230233545A1 (en) 2023-07-27
TW202214241A (zh) 2022-04-16
CA3180943A1 (en) 2021-12-23
JP2023529502A (ja) 2023-07-10
WO2021257456A1 (en) 2021-12-23
IL298885A (en) 2023-02-01
CL2022003548A1 (es) 2023-06-09
CN116056703A (zh) 2023-05-02
JP2026048841A (ja) 2026-03-17
KR20230024977A (ko) 2023-02-21
AU2021293817A1 (en) 2023-01-19

Similar Documents

Publication Publication Date Title
MX2022015488A (es) Tratamiento para la disfuncion auricular.
CL2021003045A1 (es) Tratamiento de la disfunción sistólica
PH12020551923A1 (en) Methods and compositions for treating cancer
EP4338804A3 (en) Epinephrine spray formulations
CL2021002669A1 (es) (divisional de solicitud 3443-2018) tratamientos de cancer.
BR112021020247A2 (pt) Composições e métodos para melhorar a saúde da pele e para o tratamento e prevenção de doenças, distúrbios e afecções associadas a micróbios patogênicos
MX2025006821A (es) Extractos botanicos y bacterianos que muestran actividad similar al retinol
WO2017136795A8 (en) Bacteria engineered to treat diseases associated with tryptophan metabolism
MX2020011016A (es) Composiciones para el tratamiento de condiciones de la piel.
MX2025002953A (es) Derivados heteroaromaticos y aromaticos heterobiciclicos para el tratamiento de trastornos relacionados con ferroptosis
WO2008017025A3 (en) Combination therapy
MX2023012095A (es) Inhibidores de hdac6 para el uso en el tratamiento de la miocardiopatía dilatada.
PH12022550130A1 (en) Enzyme inhibitors
MX2022009384A (es) Usos terapeuticos de la tirzepatida.
MX2014000567A (es) Tratamiento de lesion por radiacion utilizando celulas adherentes derivadas del amnios.
MX2017009963A (es) Composición y método para el tratamiento de padecimientos de la piel.
MX2020006005A (es) Copolimeros bloque anfifilicos, micelas y metodos para tratar o prevenir insuficiencia cardiaca.
MX2021006933A (es) Administración de sulcardina para el tratamiento de fibrilación auricular aguda.
MX2025004900A (es) Tratamiento de verrugas
WO2020231237A3 (ko) 위치고정튜브를 구비한 삼첨판막 역류증 시술용 기구
MX2021011289A (es) Composiciones que comprenden moduladores de isoenzima m2 muscular de piruvato cinasa pkm2 y metodos de tratamiento que usan las mismas.
ZA202207601B (en) Treatment of acute heart failure
MX2023004881A (es) Inhibidores de pde9 para el tratamiento de insuficiencia cardíaca.
WO2019227056A3 (en) Methods and compositions involving bucindolol for the treatment of atrial fibrillation
EP4321220A3 (en) A1at for reducing risk of onset of acute graft versus host disease after hematopoeitic cell transplantation